For: | Amarasinghe G, Sifrim D. Functional Esophageal Disorders: Pharmacological Options. Drugs 2014;74:1335-44. [DOI: 10.1007/s40265-014-0272-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Xuelai L, Xueyan L, Wen X. Exploring the Use of the Current Perception Threshold in Pharyngeal Paresthesia Patients. Dysphagia 2022;37:1431-9. [PMID: 34978622 DOI: 10.1007/s00455-021-10401-5] [Reference Citation Analysis] |
2 | Nassri A, Sharzehi K, Schey R. Botulinum Toxin Treatment in Gastrointestinal Disorders. Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine 2020. [DOI: 10.1007/978-3-030-50691-9_14] [Reference Citation Analysis] |
3 | Sharzehi K, Schey R. The Role of Botulinum Toxin in the Gastrointestinal Tract. Botulinum Toxin Treatment in Clinical Medicine 2018. [DOI: 10.1007/978-3-319-56038-0_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis] |
4 | Kang CH, Hentz JG, Lott DG. Muscle Tension Dysphagia: Symptomology and Theoretical Framework. Otolaryngol Head Neck Surg 2016;155:837-42. [DOI: 10.1177/0194599816657013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis] |
5 | G. CD. DOLOR TORÁCICO NO CARDIOGÉNICO. Revista Médica Clínica Las Condes 2015;26:579-585. [DOI: 10.1016/j.rmclc.2015.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis] |
6 | Adis Medical Writers. Functional oesophageal disorders must be diagnosed properly and treated accordingly. Drugs Ther Perspect 2015;31:62-65. [DOI: 10.1007/s40267-015-0182-4] [Reference Citation Analysis] |